Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 1999, p. 565-569, Vol. 37, No. 3
Departments of Biochemistry and Molecular
Biology1 and
Medicine,2 New York Medical College,
Valhalla, New York 10595
Received 12 August 1998/Returned for modification 13 October
1998/Accepted 17 November 1998
Two hundred seventeen isolates of Borrelia burgdorferi
originally cultured from skin biopsy samples or blood of early Lyme disease patients were genetically characterized by PCR-restriction fragment length polymorphism (RFLP) typing of the 16S-23S ribosomal DNA
intergenic spacer. Three major RFLP types were observed. Of the
cultured isolates, 63 of 217 (29.0%) were type 1, 85 of 217 (39.2%)
were type 2, and 58 of 217 (26.7%) were type 3; mixtures of two RFLP
types were obtained in 6.0% (13 of 217) of the cultures. Comparison of
typing of B. burgdorferi performed directly on 51 patient
skin specimens with typing of cultures originally isolated from the
same tissue revealed that a much larger proportion of direct tissue
samples had mixtures of RFLP types (43.1% by direct typing versus
5.9% by culture [P < 0.001). In addition, identical RFLP types were observed in only 35.5% (11 of 31) of the paired samples. RFLP type 3 organisms were recovered from blood at a significantly lower rate than were either type 1 or type 2 strains. These studies demonstrate that the genetic diversity of B. burgdorferi patient isolates as determined by cultivation differs
from that assessed by PCR performed directly on patient tissue.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genetic Diversity of Borrelia
burgdorferi in Lyme Disease Patients as Determined by Culture
versus Direct PCR with Clinical Specimens
*
Corresponding author. Mailing address: Department of
Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595. Phone: (914) 594-4658. Fax: (914) 594-4058. E-mail: schwartz{at}nymc.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|